ArticleScientific reports2018
Multidrug-resistant Citrobacter freundii ST139 co-producing NDM-1 and CMY-152 from China.
Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 47 citations in OpenAlex.
- Emergence and clonal dissemination of KPC-2- and NDM-1-coharboringMicrobiology spectrum · 2025Article
- Evolution, dissemination, and genetic dynamics of the carbapenem resistance geneFrontiers in cellular and infection microbiology · 2025Article
- Identification of CMY-190, a novel chromosomally encoded AmpC β-lactamase, and plasmid-encoded KPC-2 in a clinical isolate ofFrontiers in microbiology · 2025Article
- The global prevalence, formation, and evolutionary inference of bacteria co-carrying theFrontiers in microbiology · 2025Article
- Article
- Article
- Coexistence of a novel NDM-1-encoding MDR plasmid and an IMP-4-encoding IncN-IncU hybrid plasmid in a clinical isolate ofFrontiers in microbiology · 2024Article
- Deciphering mechanisms ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- Tackling Soil ARG-Carrying Pathogens with Global-Scale Metagenomics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Article
- Complete-genome sequencing and comparative genomic characterization of blaBMC genomics · 2023Article
- A brief insight intoFrontiers in antibiotics · 2023Review
- Designing mRNA- and Peptide-Based Vaccine Construct against Emerging Multidrug-ResistantMedicina (Kaunas, Lithuania) · 2022Article
- Combinations of Peptide-Protein Extracts from Native Probiotics Suppress the Growth of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2022Article
- Genetic Characterization ofInfection and drug resistance · 2022Article
- Co-Production of NDM-1 and OXA-10 β-Lactamase inInfection and drug resistance · 2022Article
- Antimicrobial Resistance and Molecular Characterization ofFrontiers in cellular and infection microbiology · 2021Article
- Characterization of Plasmid Co-Harboring NDM-1 and SHV-12 from a Multidrug-ResistantInfection and drug resistance · 2021Article
- Phenotypic Characterization and Whole-Genome Analysis of a Novel Bacteriophage HCF1 InfectingFrontiers in microbiology · 2021Article
- Article
- Pathogenomic Analysis of a Novel Extensively Drug-ResistantPathogens (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 1 country.
Funding
Abstract
The emergence of carbapenemase-producing Citrobacter freundii poses a significant threat to public health worldwide. Here, we reported a C. freundii strain CWH001 which was resistant to all tested antimicrobials except tetracycline. Whole genome sequencing and analysis were performed. The strain, which belonged to a new sequence type ST139, showed close relationship with other foreign C. freundii strains through phylogenetic analysis. A novel variant of the intrinsic bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.